GSK plc reported that several executives acquired Ordinary Shares on July 11, 2024, for £15.1279 each as part of a dividend reinvestment plan. Notably, Emma Walmsley purchased 26 shares, while other executives also made similar acquisitions ranging from 2 to 70 shares.